Bausch Health Companies (BHC) Operating Expenses (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Operating Expenses came in at $3.5 billion in Q1 2026, up 75.19% year-on-year from $2.0 billion in Q1 2025, and up 49.61% quarter-over-quarter from $2.3 billion in Q4 2025.
Bausch Health Companies (BHC) Operating Expenses (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Operating Expenses across 18 years of filings, most recently posting $3.5 billion for Q1 2026.
- Operating Expenses for Q1 2026 came in at $3.5 billion, up 75.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.9 billion (up 21.42% YoY), and the FY2025 annual result was $8.5 billion, up 4.63% from the prior year.
- Operating Expenses came in at $3.5 billion for Q1 2026 at Bausch Health Companies, up from $2.3 billion in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $3.5 billion in Q1 2026 to a low of $1.6 billion in Q1 2022.
- The 5-year median for Operating Expenses is $2.0 billion (2024), against an average of $2.1 billion.
- Across the five-year window, Operating Expenses decreased 27.36% in 2022 and jumped 75.19% in 2026, its largest moves.
- Bausch Health Companies' Operating Expenses stood at $2.4 billion in 2022, then slipped by 15.77% to $2.0 billion in 2023, then dropped by 2.2% to $2.0 billion in 2024, then advanced by 16.04% to $2.3 billion in 2025, then surged by 49.61% to $3.5 billion in 2026.
- The last three Operating Expenses figures came in at $3.5 billion (Q1 2026), $2.3 billion (Q4 2025), and $2.1 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 526.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 788.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 455.70 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 19.40 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 621.10 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 478.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 441.19 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 96.91 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 475.11 Mn |
| 10 | Bausch Health Companies | 1.91 Bn | 1.58 Bn | 2.48 Bn | 3.47 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.47 Bn |
| Dec 31, 2025 | 2.32 Bn |
| Sep 30, 2025 | 2.06 Bn |
| Jun 30, 2025 | 2.09 Bn |
| Mar 31, 2025 | 1.98 Bn |
| Dec 31, 2024 | 2.00 Bn |
| Sep 30, 2024 | 2.19 Bn |
| Jun 30, 2024 | 2.01 Bn |
| Mar 31, 2024 | 1.87 Bn |
| Dec 31, 2023 | 2.05 Bn |
| Sep 30, 2023 | 2.22 Bn |
| Jun 30, 2023 | 1.76 Bn |
| Mar 31, 2023 | 1.77 Bn |
| Dec 31, 2022 | 2.43 Bn |
| Sep 30, 2022 | 1.80 Bn |
| Jun 30, 2022 | 1.81 Bn |
| Mar 31, 2022 | 1.63 Bn |
| Dec 31, 2021 | 1.83 Bn |
| Sep 30, 2021 | 1.54 Bn |
| Jun 30, 2021 | 2.37 Bn |